Showing results (41-50 of 192) with videos related to

Sort By:
Pageof 20
Antiviral Therapy|December 25, 2009
Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype CTing-Hui Hsieh, Tai-Chung Tseng, Chun-Jen Liu, et al.
Journal of Gastroenterology and Hepatology|August 24, 2024
Rituximab carries high risks of hepatitis B virus reactivation in hematologic and rheumatic patients with chronic or resolved hepatitis BKuan-Chu Hou, Tung-Hung Su, Chien-Neng Kao, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 25, 2025
Evolution of qHBsAg levels in HBV/HCV co-infected patients with low serum HBV DNA: Comparison between treated versus untreatedJui-Hsiang Chung, Tai-Chung Tseng, Chen-Hua Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 19, 2016
Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis CYone-Han Mah, Chen-Hua Liu, Chi-Ling Chen, et al.
Gastroenterology|June 16, 2011
Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconvertersTai-Chung Tseng, Chun-Jen Liu, Tung-Hung Su, et al.
Gut and Liver|January 12, 2021
Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver DiseaseShang-Chin Huang, Hau-Jyun Su, Jia-Horng Kao, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2022
Long-term Evolution of Estimated Glomerular Filtration Rate in Patients With Antiviral Treatment for Hepatitis C Virus InfectionChen-Hua Liu, Jou-Wei Lin, Chun-Jen Liu, et al.
Frontiers in Immunology|June 18, 2020
Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint BlockadeYu-Chen Chuang, Jen-Chih Tseng, Li-Rung Huang, et al.
Pageof 20